MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$223,123K
(13.77%↑ Y/Y)
Accretion of discount on
investments, net
$7,297K
(-9.67%↓ Y/Y)
Interest and other
income, net
$3,218K
(-61.07%↓ Y/Y)
Loss from operations
-$231,747K
(15.17%↑ Y/Y)
Interest expense
$1,891K
(0.27%↑ Y/Y)
Total operating
expenses
$231,747K
(-15.17%↓ Y/Y)
Research and development
$142,015K
(-17.07%↓ Y/Y)
General and
administrative
$86,501K
(-15.16%↓ Y/Y)
Restructuring
$3,231K
Back
Back
Income Statement
source: myfinsight.com
ROCKET PHARMACEUTICALS, INC. (RCKT)
ROCKET PHARMACEUTICALS, INC. (RCKT)